Free press releases distribution network?

Agency / Source: ZOLL Medical Corporation

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

ZOLL Sponsors Latin America's First Symposium on Therapeutic Temperature Management - Keynote speakers discuss indications and success of the life-saving technology
ZOLL Sponsors Latin America's First Symposium on Therapeutic Temperature Management


PRZOOM - /newswire/ - Chelmsford, MA, United States, 2012/02/23 - Keynote speakers discuss indications and success of the life-saving technology. NASDAQ: ZOLL

Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of medical devices and related software solutions, announced today that it recently provided an education grant to sponsor the “Seminario Internacional de Hipotermia: Innovadora Modalidad de Neuroproteccion,” Latin America’s first symposium on therapeutic temperature management in Panama City, Panama. The symposium highlighted the successful use of temperature management for cooling and warming a patient’s body temperature for a range of acute neurological diseases.

The conference attracted close to 100 critical care and intensive care physicians, cardiologists, neurologists, neurosurgeons, and nurses from across the region, who came to learn about advances and case studies in this emerging field of life-saving technology.

According to Guadalupe Castillo Abrego, MD, Medical Director Neurocritical Care Unit Caja de Seguro Social Hospital and Neuro and Critical Care Staff Physician at the Johns Hopkins-affiliated Punta Pacifica Hospital, the conference presentations spanned a range of topics relevant to therapeutic hypothermia including the benefits of therapeutic hypothermia post-cardiac arrest*; physiological changes, mechanism of actions and considerations in therapeutic hypothermia patients; the importance of temperature management in the treatment of acute brain and or spinal cord injury; therapeutic hypothermia protection after cerebral ischemia and trauma; the induction, maintenance and heating during therapeutic hypothermia; the development and implementation of therapeutic hypothermia programs at hospitals; and chills and fever control in the setting of acute brain injury.

“Conference attendees were addressed by some of the foremost practitioners in this quickly emerging field of life-saving technology who were able to impart first-hand knowledge on the relevance of therapeutic hypothermia,“ said Dr. Castillo Abrego. “Attendees learned the benefits of therapeutic hypothermia for a widening range of indications, including post-cardiac arrest, head trauma, acute spinal injury, stroke, and seizures.”

“Much of the discussion was on neurological outcome for patients treated with therapeutic hypothermia, and the benefits of precise temperature control,” said James Palazzolo, President of ZOLL. “This innovative approach to neuroprotection is at the forefront of advancing critical care and improving outcomes from a range of life-altering indications.”

The panel of leading international experts in temperature management who gave keynote presentations at the conference included:

Kees Polderman, MD, PhD, University of Pittsburgh, formerly University of Utrecht, (Netherlands); Neurocritical Care Society Board Director
W. Dalton Dietrich, PhD, University of Miami, Editor in Chief of Neurotrauma Journal and Therapeutic Hypothermia and Temperature Management Journal
Gene Sung, MD, Head of the Department of Stroke and Neurointensive Care, University of California at Los Angeles (UCLA); Founding member and president of the Neurocritical Care Society International
Kiwon Lee, MD, Neurocritical Care and Stroke Neurologist, Professor of Neurocritical Care Unit, Columbia Presyterian Hospital, New York

Upcoming therapeutic hypothermia and temperature management conferences for which ZOLL is providing an educational grant in 2012 include the second annual U.S. “Chilling at the Beach,” in Miami in March and “Chilling at the Beach,” in Slovenia Europe in June.

ZOLL IVTM provides cooling and warming from a catheter inserted into a patient’s vein. This provides better control of the core body temperature by directly cooling or warming the patient’s blood as it flows through the body. This catheter is connected to the Thermogard XP® console, which when used to induce hypothermia, circulates ice-cold saline solution inside a balloon catheter. After a period of therapeutic hypothermia, typically 12-24 hours, the system slowly and accurately rewarms the patient back to normal body temperature. Since the saline flows only within the catheter, no fluid is infused into the patient. The ZOLL IVTM system is efficient, precise and easy to use, and frees up clinical staff to attend to other patient needs.

ZOLL IVTM offers a variety of catheters with placement options to handle specific patient challenges. Options for catheter placement include femoral, subclavian, and internal jugular.
About ZOLL Medical Corporation

ZOLL Medical Corporation develops and markets medical devices and related software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care.

A NASDAQ Global Select company and a Forbes 100 Most Trustworthy Company for the past three years, ZOLL develops and manufactures its products in the United States, in California, Colorado, Illinois, Massachusetts, Pennsylvania, and Rhode Island. More than 400 direct sales and service representatives, 1,100 business partners, and 200 independent representatives serve our customers in over 140 countries around the globe. For more information, visit

Certain statements contained in this press release, including statements regarding the anticipated development of the Company's business, and other statements contained herein regarding matters that are not historical facts, are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled “Risk Factors” in the Company's Annual Report on Form 10-K filed with the SEC on November 23, 2011, as updated by the Company’s subsequent SEC filings, including Quarterly Reports on Form 10-Q. You should not place undue reliance on the forward-looking statements in this press release, and the Company disavows any obligation to update or supplement those statements in the event of any changes in the facts, circumstances, or expectations that underlie those statements.

Copyright © 2012 ZOLL Medical Corporation. All rights reserved. IVTM and ZOLL are trademarks and/or registered trademarks of ZOLL Medical Corporation in the United States and/or other countries. All trademarks are the property of their respective owners.

*Not FDA approved for use in the U.S.

A. Ernest Whiton, Chief Financial Officer
P: +1 978-421-9655

Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Agency / Source: ZOLL Medical Corporation


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker


Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

# # #
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!

ZOLL Sponsors Latin America's First Symposium on Therapeutic Temperature Management

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Contact: Diane Egan - 
978-421-9637 degan[.]
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any ZOLL Medical Corporation securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Press Releases From ZOLL Medical Corporation / Company Profile

Read Medical Services/Equipment Most Recent Related Press Releases:

Frost & Sullivan Commends Influence Health for Constantly Evolving its Patient Engagement Products to Accelerate Market Transformation
Frost & Sullivan Awards Carestream Top Honors for OnSight 3D Extremity System
Sparta Systems Launches the Next-Generation Cloud Solution Stratas QMS
Koning Wins Accolades from Frost & Sullivan for the Impressive Innovation Behind its Groundbreaking KBCT Breast Imaging Device
Frost & Sullivan Awards ResMed for Developing S+ Advanced Sleep Tracking System
Sparta Systems Becomes First Quality Management Solutions Provider to Achieve EU-U.S. Privacy Shield Compliance
ZOLL Expands the Rescuer Experience at EMS World Expo
Agfa and GPMI Sign Distribution Agreement for Agfa’s Synthetic Paper Synaps
Frost & Sullivan Highlights iLine Microsystems for Developing a Microfluidics-Based Sophisticated POC Device for PT/INR Coagulation Testing
GE Healthcare’s Biosafe Announces Sefia Platform to Address Multiple Steps in Cell Therapy Production Process

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...


Visit  Demyk Lightmod Products, Inc.



  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution freenewswiredistribution asianewstoday bizwiretoday USA pr UK today